Kim Huard is one of Genentech’s Senior Scientists, and has spent a decade looking for new medicines. She spent eight years at Pfizer at the Groton and Cambridge sites before joining us in California. When I interviewed at Genentech, I asked her for one piece of advice on how to Read more…
or, How I Learned to Stop Worrying and Love My Own Definition. Recently I posted on “biologic drugs” which were approved in 2019. All was well in my little scientific universe, until I received this in an email: “You recently reported “14 novel biologic drugs,” referring to ‘novel’ biopharmaceuticals approved Read more…
Gleevec (imatinib) was the first tyrosine kinase inhibitor approved for the treatment of cancer and one of the first products to emerge from “rational drug design.” It’s invention changed chronic myeloid leukemia from an incurable death sentence to a manageable disease. Here’s a look back on the tremendous value it’s Read more…